ModernVivo Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Seed
- Investors
-
8
ModernVivo General Information
Description
Developer of an AI-powered literature review platform designed to review for superior in vivo study design. The company utilizes machine learning and natural language processing technologies to design optimized preclinical in vivo models, improving drug translation and clinical success while reducing development costs, enabling research pharmacologists to obtain well-performing in vivo models for successful drug development.
Contact Information
Website
www.modernvivo.comCorporate Office
- 1448 NorthWest Market Street
- Suite 500
- Seattle, WA 98107
- United States
Corporate Office
- 1448 NorthWest Market Street
- Suite 500
- Seattle, WA 98107
- United States
ModernVivo Timeline
ModernVivo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 10-Jun-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 30-Oct-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 19-Sep-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jul-2023 | Completed | Generating Revenue | |||
| 1. Grant | 22-Feb-2023 | $6.5K | Completed | Generating Revenue |
ModernVivo Patents
ModernVivo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260010561-A1 | Clustering terms using machine learning models | Inactive | 03-Jul-2024 |
ModernVivo Signals
ModernVivo Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Blackwood Healthcare Breakthroughs | Venture Capital | Minority | ||
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | ||
| Michigan Biomedical Venture Fund | Venture Capital | Minority | ||
| Merck Digital Sciences Studio | Accelerator/Incubator | |||
| Creative Destruction Lab | Accelerator/Incubator |
ModernVivo FAQs
-
When was ModernVivo founded?
ModernVivo was founded in 2022.
-
Where is ModernVivo headquartered?
ModernVivo is headquartered in Seattle, WA.
-
What is the size of ModernVivo?
ModernVivo has 8 total employees.
-
What industry is ModernVivo in?
ModernVivo’s primary industry is Discovery Tools (Healthcare).
-
Is ModernVivo a private or public company?
ModernVivo is a Private company.
-
What is ModernVivo’s current revenue?
The current revenue for ModernVivo is .
-
Who are ModernVivo’s investors?
Blackwood Healthcare Breakthroughs, Debiopharm Innovation Fund, Michigan Biomedical Venture Fund, Merck Digital Sciences Studio, and Creative Destruction Lab are 5 of 8 investors who have invested in ModernVivo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process